Clinical role of GM-CSF in neutrophil recovery in relation to health care parameters

被引：0

作者：

Hofstra, LS ^{[1
]}

DeVries, EGE ^{[1
]}

UylDeGroot, CA ^{[1
]}

Vellenga, E ^{[1
]}

机构：

[1] UNIV GRONINGEN HOSP, DEPT HEMATOL, NL-9700 RB GRONINGEN, NETHERLANDS

来源：

MEDICAL ONCOLOGY | 1996年 / 13卷 / 03期

关键词：

GM-CSF; neutrophil recovery; health care;

D O I：

10.1007/BF02990845

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Recombinant human growth factors, particularly granulocyte-macrophage colony-stimulating factor (GM-CSF), have been only available for a few years. Since their introduction they have affected the management of drug-induced neutropenia, the use of dose intensive chemotherapy regimens and in the setting of autologous stem cell transplantation. This review addresses the clinical role of GM-CSF, using the data available, in neutrophil recovery in relation to various health care parameters.

引用

页码：177 / 184

页数：8

共 70 条

[1] EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON CHEMOTHERAPY-INDUCED MYELOSUPPRESSION [J].

ANTMAN, KS ;

GRIFFIN, JD ;

ELIAS, A ;

SOCINSKI, MA ;

RYAN, L ;

CANNISTRA, SA ;

OETTE, D ;

WHITLEY, M ;

FREI, E ;

SCHNIPPER, LE .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (10) :593-598

[2] INTERLEUKIN-1 STIMULATES GRANULOCYTE MACROPHAGE COLONY-STIMULATING ACTIVITY RELEASE BY VASCULAR ENDOTHELIAL-CELLS [J].

BAGBY, GC ;

DINARELLO, CA ;

WALLACE, P ;

WAGNER, C ;

HEFENEIDER, S ;

MCCALL, E .

JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (05) :1316-1323

[3]

BASH RO, 1994, CANCER, V74, P189, DOI 10.1002/1097-0142(19940701)74:1<189::AID-CNCR2820740130>3.0.CO

[4]

2-7

[5] FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS [J].

BENSINGER, W ;

APPELBAUM, F ;

ROWLEY, S ;

STORB, R ;

SANDERS, J ;

LILLEBY, K ;

GOOLEY, T ;

DEMIRER, T ;

SCHIFFMAN, K ;

WEAVER, C ;

CLIFT, R ;

CHAUNCEY, T ;

KLARNET, J ;

MONTGOMERY, P ;

PETERSDORF, S ;

WEIDEN, P ;

WITHERSPOON, R ;

BUCKNER, CD .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (10) :2547-2555

[6] ROLE OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS ADJUVANT TREATMENT IN NEUTROPENIC PATIENTS WITH BACTERIAL AND FUNGAL INFECTION [J].

BODEY, GP ;

ANAISSIE, E ;

GUTTERMAN, J ;

VADHANRAJ, S .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1994, 13 :S18-S22

[7]

BOLWELL BJ, 1993, BONE MARROW TRANSPL, V12, P609

[8] EFFECT OF RECOMBINANT HUMAN GRANULOCYTE MACROPHAGE COLONY-STIMULATING FACTOR ON HEMATOPOIETIC RECONSTITUTION AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS BONE-MARROW TRANSPLANTATION [J].

BRANDT, SJ ;

PETERS, WP ;

ATWATER, SK ;

KURTZBERG, J ;

BOROWITZ, MJ ;

JONES, RB ;

SHPALL, EJ ;

BAST, RC ;

GILBERT, CJ ;

OETTE, DH .

NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (14) :869-876

[9] SEQUENTIAL ADMINISTRATION OF INTERLEUKIN-3 AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOLLOWING STANDARD-DOSE COMBINATION CHEMOTHERAPY WITH ETOPOSIDE, IFOSFAMIDE, AND CISPLATIN [J].

BRUGGER, W ;

FRISCH, J ;

SCHULZ, G ;

PRESSLER, K ;

MERTELSMANN, R ;

KANZ, L .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (09) :1452-1459

[10] CHEMORADIOTHERAPY WITH OR WITHOUT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN THE TREATMENT OF LIMITED-STAGE SMALL-CELL LUNG-CANCER - A PROSPECTIVE PHASE-III RANDOMIZED STUDY OF THE SOUTHWEST-ONCOLOGY-GROUP [J].

BUNN, PA ;

CROWLEY, J ;

KELLY, K ;

HAZUKA, MB ;

BEASLEY, K ;

UPCHURCH, C ;

LIVINGSTON, R .

JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (07) :1632-1641

← 1 2 3 4 5 6 7 →